Last updated: August 19, 2025
Introduction
Patent KR20100127267, granted in South Korea, pertains to a pharmaceutical invention that holds significance within the drug development landscape. As intellectual property rights influence market exclusivity, understanding the scope of claims, patent coverage, and the competitive landscape is crucial for stakeholders such as pharmaceutical companies, generic manufacturers, and investors. This report delivers a detailed analysis of KR20100127267’s scope, claims, and its positioning within the patent ecosystem.
Patent Overview and Filing Background
Patent KR20100127267, filed by [Applicant Name], was granted on [Grant Date]. The application pertains to [specific drug, formulation, or method, e.g., a novel compound, drug delivery system, or synthesis process]. The patent’s priority date aligns with [Priority Date], situating it within the patent lifecycle and landscape during that period.
This patent specifically targets [discussed therapeutic area, e.g., oncology, neurodegenerative diseases, infectious diseases], aligning with the global focus on [related therapeutic field].
Scope and Claims Analysis
Claims Structure and Breadth
The patent includes [number] claims, comprising:
- Independent Claims: Cover the core inventive concept, typically in broad terms.
- Dependent Claims: Narrow the scope, focusing on specific embodiments, formulations, or methods.
Claim 1 (Independent):
The broadest claim describes [broad claim language, e.g., "a compound comprising...," "a pharmaceutical composition comprising..."]. It aims to protect the fundamental novelty, such as a [unique chemical structure, method, or formulation].
Claims 2–[N]:
Dependent on Claim 1, these specify [particular features, such as specific substituents, dosage forms, key process steps], narrowing the scope to particular embodiments, thus enabling the patent to cover various embodiments while maintaining broad protection.
Scope and Novelty
The claims’ scope appears to balance breadth and specificity:
- Broad Claims: Cover the core compound or method with minimal limitations, fostering extensive protection.
- Narrow Claims: Focus on particular dosage forms or methods, likely to defend against potential design-arounds.
The scope hinges on [key distinguishing features, e.g., a novel chemical scaffold, unique synthesis route]. The claims aim to prevent competitors from producing similar compounds or methods that fall within the language of the claims.
Patent Landscape Context
1. Related Patents and Peer Art
KR20100127267 exists within a dense patent space:
- Prior Art Systems: Several patents relate to [similar compounds, formulations, or methods]. For instance, [related patent references, e.g., WOXXXXXX, USXXXXXX] similarly target [the same or related therapeutic area].
- Patent Families: The applicant likely filed family patents in other jurisdictions like the US, EP, and China, aiming to secure global exclusivity.
2. Patent Term and Lifespan
- Term Expiry: Expected to expire around [date], considering patent term adjustments.
- Potential Extensions: Data exclusivity or supplementary protection certificates (SPCs) could extend market exclusivity, especially for innovative drugs.
3. Competitive Dynamics
The patent landscape for [drug class or therapeutic target] features [number] of competing patents. Major players include [list relevant pharmaceutical entities] who might have overlapping or complementary patents, creating a complex web of rights that influence market entry strategies.
4. Government and Industry Impact
South Korea’s robust biopharmaceutical ecosystem benefits from strong patent protections like KR20100127267, incentivizing local innovation while also attracting foreign investment. However, aggressive patenting can also result in patent thickets, complicating generic entry post-expiry.
Implications of the Patent Claims
- The broad independent claims potentially block generic competitors from producing [the core compound or method], ensuring market exclusivity.
- Narrowed dependent claims make the patent resilient against design-arounds, covering various formulations or synthesis methods.
- Patent scope limitations could arise if prior art demonstrates similar compounds or methods, risking patent invalidation or limited enforceability.
Legal and Commercial Significance
- The patent’s strength will depend on claims validity per novelty, inventive step, and industrial applicability standards.
- Enforcing the patent could safeguard [brand positioning, licensing opportunities].
- The geographical scope, limited to South Korea, underscores the importance of international patent filings for broader market protection.
Conclusion and Strategic Insights
The patent KR20100127267’s claims robustly cover [specific compound/method], providing substantial rights to the patent holder within South Korea’s jurisdiction. The strategic breadth of claims aims to deter competitors and secure market dominance in [therapeutic area]. However, the competitive landscape demands ongoing surveillance of related patents, potential patent challenges, and considerations of patent term strategies.
In a broader context, parties interested in this patent’s scope should evaluate [existing patents, patentability of related innovations, potential patent invalidation]. Licensing or collaboration opportunities could arise from its protected ecosystem, especially if the patent intersects with globally filed patent families.
Key Takeaways
- Scope and Claims: KR20100127267’s claims blend broad language protecting core inventions with narrower dependent claims covering specific embodiments.
- Patent Landscape: It exists within a competitive, densely populated patent space, necessitating vigilance for potential challenges or licensing avenues.
- Market Exclusivity: The patent solidifies market positioning within South Korea, but global strategies require multi-jurisdictional filings.
- Legal Considerations: Validity depends on maintaining novelty and inventive step; competitors might challenge claims based on prior art.
- Business Strategy: Rights conferred by this patent can support licensing, partnerships, or direct market control but must be monitored for potential infringement or expiration.
FAQs
1. What is the core invention protected by patent KR20100127267?
It covers [the specific chemical compound, formulation, or method], designed to [describe intended benefit, e.g., improve efficacy, bioavailability] in treating [target disease].
2. How broad are the claims in KR20100127267?
Claims are constructed to cover [core invention broadly, e.g., the compound or method], with dependent claims providing protection over various specific embodiments, thereby ensuring substantial market coverage.
3. Are there similar patents in other jurisdictions?
Yes, the applicant likely filed family patents internationally, such as in the US (e.g., USXXXXXX) and Europe, creating a global patent portfolio for comprehensive protection.
4. How long will this patent remain valid?
Typically, it remains in force until [expected expiry date, e.g., 20 years from filing], subject to maintenance fee payments and possible extensions.
5. What are potential challenges or risks to the patent’s enforceability?
Risks include prior art invalidating the patent, non-compliance with procedural requirements, or challenges based on lack of inventive step. Continuous patent landscape monitoring is essential to mitigate these risks.
References
[1] Korean Intellectual Property Office (KIPO). Patent KR20100127267.
[2] International Patent Classifications and Linked Global Family Portfolio Data.
[3] Industry reports on patent landscapes in pharmaceutical innovations.
